Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.

作者: Zachary S. Morris , Jamey P. Weichert , Jarob Saker , Eric A. Armstrong , Abigail Besemer

DOI: 10.1016/J.RADONC.2015.06.015

关键词:

摘要: Abstract Background and purpose CLR1404 is a phospholipid ether that exhibits selective uptake retention in malignant tissues. Radiolabeled enables tumor-specific positron-emission tomography (PET) imaging ( 124 I) targeted delivery of ionizing radiation 131 I). Here we describe the first preclinical studies this diapeutic molecule head neck cancer (HNC) models. Material methods Tumor-selective distribution I-CLR1404 therapeutic efficacy were tested HNC cell lines patient-derived xenograft tumor Monte Carlo dose calculations PET/CT used to examine dosimetry Results including xenografts demonstrate tumor-selective resulting model highly conformal for I-CLR1404. We observe dose-dependent response with respect growth inhibition effect maintained together external beam radiation. Conclusions confirm utility treatment HNC. This promising agent warrants further investigation developing phase I trial combining reduced-dose patients loco-regionally recurrent

参考文章(28)
Fred Snyder, Randall Wood, Alkyl and Alk-1-enyl Ethers of Glycerol in Lipids from Normal and Neoplastic Human Tissues Cancer Research. ,vol. 29, pp. 251- 257 ,(1969)
María P Carrasco, José M Jiménez‐López, Pablo Ríos‐Marco, Josefa L Segovia, Carmen Marco, None, Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues. British Journal of Pharmacology. ,vol. 160, pp. 355- 366 ,(2010) , 10.1111/J.1476-5381.2010.00689.X
Maura L. Gillison, HPV and prognosis for patients with oropharynx cancer. European Journal of Cancer. ,vol. 45, pp. 383- 385 ,(2009) , 10.1016/S0959-8049(09)70058-9
Andrew P. Stein, Sandeep Saha, Cheng Z. Liu, Gregory K. Hartig, Paul F. Lambert, Randall J. Kimple, Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts. PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0100995
Faustino Mollinedo, Antitumour ether lipids: proapoptotic agents with multiple therapeutic indications Expert Opinion on Therapeutic Patents. ,vol. 17, pp. 385- 405 ,(2007) , 10.1517/13543776.17.4.385
Joseph J. Grudzinski, Benjamin Titz, Kevin Kozak, William Clarke, Ernest Allen, LisaAnn Trembath, Michael Stabin, John Marshall, Steve Y. Cho, Terence Z. Wong, Joanne Mortimer, Jamey P. Weichert, A Phase 1 Study of 131I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety PLoS ONE. ,vol. 9, pp. e111652- ,(2014) , 10.1371/JOURNAL.PONE.0111652
Richard Taschereau, Arion F. Chatziioannou, Monte Carlo simulations of absorbed dose in a mouse phantom from 18‐fluorine compounds Medical Physics. ,vol. 34, pp. 1026- 1036 ,(2007) , 10.1118/1.2558115
Fred Snyder, M.L. Blank, Harold P. Morris, Occurrence and nature of O-alkyl and O-alk-1-enyl moieties of glycerol in lipids of morris transplanted hepatomas and normal rat liver Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. ,vol. 176, pp. 502- 510 ,(1969) , 10.1016/0005-2760(69)90217-3
Wim van Blitterswijk, Marcel Verheij, Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Current Pharmaceutical Design. ,vol. 14, pp. 2061- 2074 ,(2008) , 10.2174/138161208785294636
William M. Mendenhall, Charles M. Mendenhall, Robert S. Malyapa, Jatinder R. Palta, Nancy P. Mendenhall, Re-irradiation of head and neck carcinoma. American Journal of Clinical Oncology. ,vol. 31, pp. 393- 398 ,(2008) , 10.1097/COC.0B013E3181637398